Meta To Tap Wind And Solar Power For A.I. Data Centres
Technology giant Meta Platforms (META) is planning to power some of its artificial intelligence (A.I.) data centres with renewable energy sources such as wind and solar.The Silicon Valley-based company run by CEO Mark Zuckerberg has signed a deal with privately held clean energy provider Invenergy to supply it’s A.I. data centres with 791 megawatts more of solar and wind power, the companies announced in a news release.This is the latest deal that Meta Platforms has signed to help meet its soaring power needs as it races to bring data centres online that can power it’s A.I. technologies and applications. This is Meta’s second deal with Invenergy. In 2024, Meta signed a contract with the Chicago-based renewable energy provider for 760 MW of solar electricity. The combined deals bring the companies’ total partnership to 1,800 MW.Meta has also inked deals with several large solar power providers, a geothermal start-up company, and is seeking proposals from nuclear power developers. The moves come as Meta rushes to bring A.I. data centres online and keep up with rivals such as Microsoft (MSFT).The electricity from Invenergy’s solar and wind projects situated in Ohio, Arkansas and Texas will be delivered to the local grid, while Meta will receive clean energy credits associated with the new generation capacity coming online, said the companies. META stock is up 22% this year and trading at $733.63 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


